Dopamine signaling
Showing 1 - 25 of 1,927
Diabetes, Type 2 Trial in Tuebingen (intranasal insulin, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- intranasal insulin
- Placebo
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Jun 24, 2021
Cocaine Abuse Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Brain Dopamine Reactivity, Brain
Suspended
- Cocaine Abuse
- Brain Dopamine Reactivity
- Brain Dopamine Receptor
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Vigor and the LDR in Parkinson Disease
Recruiting
- Parkinson Disease
- carbidopa/levodopa, as prescribed by treating physician
-
Ann Arbor, MichiganUniversity of Michigan
Dec 1, 2022
MDD Trial in Tübingen (Ghrelin, Placebo)
Recruiting
- Major Depressive Disorder
- Ghrelin
- Placebo
-
Tübingen, BW, GermanyDepartment of Psychiatry & Psychotherapy, University of Tübingen
Apr 7, 2022
Stress Response Trial (tDCS actif, tDCS Sham)
Not yet recruiting
- Stress Response
- tDCS actif
- tDCS Sham
- (no location specified)
Apr 20, 2023
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Learning and Decision Making
Completed
- Polymorphism- Genetic
- Reward Mediating System
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 21, 2022
Overweight and Obesity, Eating Behavior Trial in Chapel Hill (Placebo, Bromocriptine-QR)
Completed
- Overweight and Obesity
- Eating Behavior
- Placebo
- Bromocriptine-QR
-
Chapel Hill, North CarolinaUniversity of North Carolina, Chapel Hill
Aug 12, 2022
Caffeine Trial in Basel (caffeine, mannitol)
Recruiting
- Caffeine
- caffeine
- mannitol
-
Basel, Basel City, SwitzerlandCentre for Chronobiology, University Psychiatric Clinics Basel
May 20, 2022
Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)
Enrolling by invitation
- Dopamine D2/3 Receptor Availability
- +2 more
- Varenicline
- Placebo
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Mar 2, 2022
Diabetes, Obesity Trial in Nashville (Detemir)
Active, not recruiting
- Diabetes
- Obesity
-
Nashville, TennesseeVanderbilt University
Sep 7, 2021
Pathophysiology of Gilles de la Tourette Syndrome. Part 1:
Not yet recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- PET/MR scanner
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 11, 2022
Obesity Trial in New York (Naltrexone-Bupropion Combination)
Recruiting
- Obesity
- Naltrexone-Bupropion Combination
-
New York, New YorkColumbia University Medical Center
Jun 16, 2023
Stimulant Use and Methylation in HIV
Completed
- HIV Infections
- +2 more
-
Miami, FloridaUniversity of Miami
Jun 14, 2023
Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T
Recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- MRI scanner (7 Tesla)
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 10, 2022
Neuroimaging Studies of Reward Processing in Depression
Completed
- Major Depressive Disorder
- PET Scan with Raclopride
-
Belmont, MassachusettsDavid Crowley
Feb 1, 2023
Multiple System Atrophy Trial in Bordeaux (biological, behavioral, procedure)
Recruiting
- Multiple System Atrophy
- Homeostasis Model Assessment of insulin resistance (HOMA)
- +4 more
-
Bordeaux, FranceCHU de Bordeaux
Mar 29, 2022
Investigating Serotonin Signalling in IBD Patients
Recruiting
- Inflammatory Bowel Disease
-
Hamilton, Ontario, CanadaMcMaster University Medical Center
Sep 9, 2021
Treatment Resistant Depression Trial in New York (Tianeptine Sodium)
Recruiting
- Treatment Resistant Depression
- Tianeptine Sodium
-
New York, New York1051 Riverside Drive
Jul 18, 2022
Schizophrenia Trial in Shanghai (sodium valproate with Clozapine, modified electroconvulsive therapy(MECT) with Clozapine,
Completed
- Schizophrenia
- sodium valproate with Clozapine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 1, 2022
Stimulant Use Disorder, Substance-related Disorders Trial in Palo Alto (Repetitive transcranial magnetic stimulation (rTMS))
Recruiting
- Stimulant Use Disorder
- Substance-related Disorders
- Repetitive transcranial magnetic stimulation (rTMS)
-
Palo Alto, CaliforniaVA Palo Alto Health Care System, Palo Alto, CA
Feb 24, 2022
Parkinson Disease, Apathy Trial (Psychosocial intervention, Methylphenidate)
Not yet recruiting
- Parkinson Disease
- Apathy
- Psychosocial intervention
- Methylphenidate
- (no location specified)
Dec 28, 2022
Measuring Brain Activity of School Age Children
Completed
- Perinatal Hypoxia
- +2 more
- Magnetic Resonance Imaging
- +2 more
-
Cleveland, OhioCase Western Reserve University
Dec 13, 2021
Brachial Plexus Injury Trial in Rochester (Ketamine Infustion)
Enrolling by invitation
- Brachial Plexus Injury
- Ketamine Infustion
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 29, 2022